We've found
33,560
archived clinical trials in
Neurology
We've found
33,560
archived clinical trials in
Neurology
Trevo® Retriever Registry Post Market Surveillance
Updated: 1/9/2018
Stryker Neurovascular Trevo® Retriever Registry
Status: Enrolling
Updated: 1/9/2018
Trevo® Retriever Registry Post Market Surveillance
Updated: 1/9/2018
Stryker Neurovascular Trevo® Retriever Registry
Status: Enrolling
Updated: 1/9/2018
Click here to add this to my saved trials
Trevo® Retriever Registry Post Market Surveillance
Updated: 1/9/2018
Stryker Neurovascular Trevo® Retriever Registry
Status: Enrolling
Updated: 1/9/2018
Trevo® Retriever Registry Post Market Surveillance
Updated: 1/9/2018
Stryker Neurovascular Trevo® Retriever Registry
Status: Enrolling
Updated: 1/9/2018
Click here to add this to my saved trials
Trevo® Retriever Registry Post Market Surveillance
Updated: 1/9/2018
Stryker Neurovascular Trevo® Retriever Registry
Status: Enrolling
Updated: 1/9/2018
Trevo® Retriever Registry Post Market Surveillance
Updated: 1/9/2018
Stryker Neurovascular Trevo® Retriever Registry
Status: Enrolling
Updated: 1/9/2018
Click here to add this to my saved trials
Trevo® Retriever Registry Post Market Surveillance
Updated: 1/9/2018
Stryker Neurovascular Trevo® Retriever Registry
Status: Enrolling
Updated: 1/9/2018
Trevo® Retriever Registry Post Market Surveillance
Updated: 1/9/2018
Stryker Neurovascular Trevo® Retriever Registry
Status: Enrolling
Updated: 1/9/2018
Click here to add this to my saved trials
Trevo® Retriever Registry Post Market Surveillance
Updated: 1/9/2018
Stryker Neurovascular Trevo® Retriever Registry
Status: Enrolling
Updated: 1/9/2018
Trevo® Retriever Registry Post Market Surveillance
Updated: 1/9/2018
Stryker Neurovascular Trevo® Retriever Registry
Status: Enrolling
Updated: 1/9/2018
Click here to add this to my saved trials
Trevo® Retriever Registry Post Market Surveillance
Updated: 1/9/2018
Stryker Neurovascular Trevo® Retriever Registry
Status: Enrolling
Updated: 1/9/2018
Trevo® Retriever Registry Post Market Surveillance
Updated: 1/9/2018
Stryker Neurovascular Trevo® Retriever Registry
Status: Enrolling
Updated: 1/9/2018
Click here to add this to my saved trials
Trevo® Retriever Registry Post Market Surveillance
Updated: 1/9/2018
Stryker Neurovascular Trevo® Retriever Registry
Status: Enrolling
Updated: 1/9/2018
Trevo® Retriever Registry Post Market Surveillance
Updated: 1/9/2018
Stryker Neurovascular Trevo® Retriever Registry
Status: Enrolling
Updated: 1/9/2018
Click here to add this to my saved trials
Trevo® Retriever Registry Post Market Surveillance
Updated: 1/9/2018
Stryker Neurovascular Trevo® Retriever Registry
Status: Enrolling
Updated: 1/9/2018
Trevo® Retriever Registry Post Market Surveillance
Updated: 1/9/2018
Stryker Neurovascular Trevo® Retriever Registry
Status: Enrolling
Updated: 1/9/2018
Click here to add this to my saved trials
Trevo® Retriever Registry Post Market Surveillance
Updated: 1/9/2018
Stryker Neurovascular Trevo® Retriever Registry
Status: Enrolling
Updated: 1/9/2018
Trevo® Retriever Registry Post Market Surveillance
Updated: 1/9/2018
Stryker Neurovascular Trevo® Retriever Registry
Status: Enrolling
Updated: 1/9/2018
Click here to add this to my saved trials
Trevo® Retriever Registry Post Market Surveillance
Updated: 1/9/2018
Stryker Neurovascular Trevo® Retriever Registry
Status: Enrolling
Updated: 1/9/2018
Trevo® Retriever Registry Post Market Surveillance
Updated: 1/9/2018
Stryker Neurovascular Trevo® Retriever Registry
Status: Enrolling
Updated: 1/9/2018
Click here to add this to my saved trials
Trevo® Retriever Registry Post Market Surveillance
Updated: 1/9/2018
Stryker Neurovascular Trevo® Retriever Registry
Status: Enrolling
Updated: 1/9/2018
Trevo® Retriever Registry Post Market Surveillance
Updated: 1/9/2018
Stryker Neurovascular Trevo® Retriever Registry
Status: Enrolling
Updated: 1/9/2018
Click here to add this to my saved trials
Trevo® Retriever Registry Post Market Surveillance
Updated: 1/9/2018
Stryker Neurovascular Trevo® Retriever Registry
Status: Enrolling
Updated: 1/9/2018
Trevo® Retriever Registry Post Market Surveillance
Updated: 1/9/2018
Stryker Neurovascular Trevo® Retriever Registry
Status: Enrolling
Updated: 1/9/2018
Click here to add this to my saved trials
Trevo® Retriever Registry Post Market Surveillance
Updated: 1/9/2018
Stryker Neurovascular Trevo® Retriever Registry
Status: Enrolling
Updated: 1/9/2018
Trevo® Retriever Registry Post Market Surveillance
Updated: 1/9/2018
Stryker Neurovascular Trevo® Retriever Registry
Status: Enrolling
Updated: 1/9/2018
Click here to add this to my saved trials
Trevo® Retriever Registry Post Market Surveillance
Updated: 1/9/2018
Stryker Neurovascular Trevo® Retriever Registry
Status: Enrolling
Updated: 1/9/2018
Trevo® Retriever Registry Post Market Surveillance
Updated: 1/9/2018
Stryker Neurovascular Trevo® Retriever Registry
Status: Enrolling
Updated: 1/9/2018
Click here to add this to my saved trials
Trevo® Retriever Registry Post Market Surveillance
Updated: 1/9/2018
Stryker Neurovascular Trevo® Retriever Registry
Status: Enrolling
Updated: 1/9/2018
Trevo® Retriever Registry Post Market Surveillance
Updated: 1/9/2018
Stryker Neurovascular Trevo® Retriever Registry
Status: Enrolling
Updated: 1/9/2018
Click here to add this to my saved trials
Trevo® Retriever Registry Post Market Surveillance
Updated: 1/9/2018
Stryker Neurovascular Trevo® Retriever Registry
Status: Enrolling
Updated: 1/9/2018
Trevo® Retriever Registry Post Market Surveillance
Updated: 1/9/2018
Stryker Neurovascular Trevo® Retriever Registry
Status: Enrolling
Updated: 1/9/2018
Click here to add this to my saved trials
Trevo® Retriever Registry Post Market Surveillance
Updated: 1/9/2018
Stryker Neurovascular Trevo® Retriever Registry
Status: Enrolling
Updated: 1/9/2018
Trevo® Retriever Registry Post Market Surveillance
Updated: 1/9/2018
Stryker Neurovascular Trevo® Retriever Registry
Status: Enrolling
Updated: 1/9/2018
Click here to add this to my saved trials
Trevo® Retriever Registry Post Market Surveillance
Updated: 1/9/2018
Stryker Neurovascular Trevo® Retriever Registry
Status: Enrolling
Updated: 1/9/2018
Trevo® Retriever Registry Post Market Surveillance
Updated: 1/9/2018
Stryker Neurovascular Trevo® Retriever Registry
Status: Enrolling
Updated: 1/9/2018
Click here to add this to my saved trials
Trevo® Retriever Registry Post Market Surveillance
Updated: 1/9/2018
Stryker Neurovascular Trevo® Retriever Registry
Status: Enrolling
Updated: 1/9/2018
Trevo® Retriever Registry Post Market Surveillance
Updated: 1/9/2018
Stryker Neurovascular Trevo® Retriever Registry
Status: Enrolling
Updated: 1/9/2018
Click here to add this to my saved trials
Evaluation of Minimally Invasive Subcortical Parafascicular Access for Clot Evacuation
Updated: 1/9/2018
Minimally Invasive Subcortical Parafascicular Access for Clot Evacuation
Status: Enrolling
Updated: 1/9/2018
Evaluation of Minimally Invasive Subcortical Parafascicular Access for Clot Evacuation
Updated: 1/9/2018
Minimally Invasive Subcortical Parafascicular Access for Clot Evacuation
Status: Enrolling
Updated: 1/9/2018
Click here to add this to my saved trials
Evaluation of Minimally Invasive Subcortical Parafascicular Access for Clot Evacuation
Updated: 1/9/2018
Minimally Invasive Subcortical Parafascicular Access for Clot Evacuation
Status: Enrolling
Updated: 1/9/2018
Evaluation of Minimally Invasive Subcortical Parafascicular Access for Clot Evacuation
Updated: 1/9/2018
Minimally Invasive Subcortical Parafascicular Access for Clot Evacuation
Status: Enrolling
Updated: 1/9/2018
Click here to add this to my saved trials
Evaluation of Minimally Invasive Subcortical Parafascicular Access for Clot Evacuation
Updated: 1/9/2018
Minimally Invasive Subcortical Parafascicular Access for Clot Evacuation
Status: Enrolling
Updated: 1/9/2018
Evaluation of Minimally Invasive Subcortical Parafascicular Access for Clot Evacuation
Updated: 1/9/2018
Minimally Invasive Subcortical Parafascicular Access for Clot Evacuation
Status: Enrolling
Updated: 1/9/2018
Click here to add this to my saved trials
Evaluation of Minimally Invasive Subcortical Parafascicular Access for Clot Evacuation
Updated: 1/9/2018
Minimally Invasive Subcortical Parafascicular Access for Clot Evacuation
Status: Enrolling
Updated: 1/9/2018
Evaluation of Minimally Invasive Subcortical Parafascicular Access for Clot Evacuation
Updated: 1/9/2018
Minimally Invasive Subcortical Parafascicular Access for Clot Evacuation
Status: Enrolling
Updated: 1/9/2018
Click here to add this to my saved trials
Evaluation of Minimally Invasive Subcortical Parafascicular Access for Clot Evacuation
Updated: 1/9/2018
Minimally Invasive Subcortical Parafascicular Access for Clot Evacuation
Status: Enrolling
Updated: 1/9/2018
Evaluation of Minimally Invasive Subcortical Parafascicular Access for Clot Evacuation
Updated: 1/9/2018
Minimally Invasive Subcortical Parafascicular Access for Clot Evacuation
Status: Enrolling
Updated: 1/9/2018
Click here to add this to my saved trials
Evaluation of Minimally Invasive Subcortical Parafascicular Access for Clot Evacuation
Updated: 1/9/2018
Minimally Invasive Subcortical Parafascicular Access for Clot Evacuation
Status: Enrolling
Updated: 1/9/2018
Evaluation of Minimally Invasive Subcortical Parafascicular Access for Clot Evacuation
Updated: 1/9/2018
Minimally Invasive Subcortical Parafascicular Access for Clot Evacuation
Status: Enrolling
Updated: 1/9/2018
Click here to add this to my saved trials
Evaluation of Minimally Invasive Subcortical Parafascicular Access for Clot Evacuation
Updated: 1/9/2018
Minimally Invasive Subcortical Parafascicular Access for Clot Evacuation
Status: Enrolling
Updated: 1/9/2018
Evaluation of Minimally Invasive Subcortical Parafascicular Access for Clot Evacuation
Updated: 1/9/2018
Minimally Invasive Subcortical Parafascicular Access for Clot Evacuation
Status: Enrolling
Updated: 1/9/2018
Click here to add this to my saved trials
Evaluation of Minimally Invasive Subcortical Parafascicular Access for Clot Evacuation
Updated: 1/9/2018
Minimally Invasive Subcortical Parafascicular Access for Clot Evacuation
Status: Enrolling
Updated: 1/9/2018
Evaluation of Minimally Invasive Subcortical Parafascicular Access for Clot Evacuation
Updated: 1/9/2018
Minimally Invasive Subcortical Parafascicular Access for Clot Evacuation
Status: Enrolling
Updated: 1/9/2018
Click here to add this to my saved trials
Imatinib Mesylate (Gleevec) in the Treatment of Systemic Sclerosis
Updated: 1/9/2018
Phase IIA Study of the Safety and Tolerability of the Use of Imatinib Mesylate (Gleevec) in the Treatment of Systemic Sclerosis
Status: Enrolling
Updated: 1/9/2018
Imatinib Mesylate (Gleevec) in the Treatment of Systemic Sclerosis
Updated: 1/9/2018
Phase IIA Study of the Safety and Tolerability of the Use of Imatinib Mesylate (Gleevec) in the Treatment of Systemic Sclerosis
Status: Enrolling
Updated: 1/9/2018
Click here to add this to my saved trials
Cognitive Rehabilitation:ACTION Training for Soldiers With Executive Dysfunction
Updated: 1/9/2018
Cognitive Rehabilitation:ACTION Training for Soldiers With Executive Dysfunction
Status: Enrolling
Updated: 1/9/2018
Cognitive Rehabilitation:ACTION Training for Soldiers With Executive Dysfunction
Updated: 1/9/2018
Cognitive Rehabilitation:ACTION Training for Soldiers With Executive Dysfunction
Status: Enrolling
Updated: 1/9/2018
Click here to add this to my saved trials
A Study Comparing the Quality of Life of Patients in the Treatment of Eczema by Pediatric Generalists and Specialists
Updated: 1/9/2018
Patient and Caregiver Quality of Life in the Treatment of Atopic Dermatitis in Pediatric Patients: a Comparison Between a General Pediatric Practice and a Pediatric Dermatology Practice
Status: Enrolling
Updated: 1/9/2018
A Study Comparing the Quality of Life of Patients in the Treatment of Eczema by Pediatric Generalists and Specialists
Updated: 1/9/2018
Patient and Caregiver Quality of Life in the Treatment of Atopic Dermatitis in Pediatric Patients: a Comparison Between a General Pediatric Practice and a Pediatric Dermatology Practice
Status: Enrolling
Updated: 1/9/2018
Click here to add this to my saved trials
Acupuncture Chemotherapy-Induced Peripheral Neuropathy (CIPN) IRG
Updated: 1/10/2018
A Phase I-II Study of Acupuncture for the Treatment of Chronic, Taxane-Induced Peripheral Neuropathy in Breast Cancer Survivors
Status: Enrolling
Updated: 1/10/2018
Acupuncture Chemotherapy-Induced Peripheral Neuropathy (CIPN) IRG
Updated: 1/10/2018
A Phase I-II Study of Acupuncture for the Treatment of Chronic, Taxane-Induced Peripheral Neuropathy in Breast Cancer Survivors
Status: Enrolling
Updated: 1/10/2018
Click here to add this to my saved trials
Magnetic Resonance and Optical Imaging of Dystrophic and Damaged Muscle
Updated: 1/10/2018
Optical Imaging of Dystrophic and Damaged Muscle
Status: Enrolling
Updated: 1/10/2018
Magnetic Resonance and Optical Imaging of Dystrophic and Damaged Muscle
Updated: 1/10/2018
Optical Imaging of Dystrophic and Damaged Muscle
Status: Enrolling
Updated: 1/10/2018
Click here to add this to my saved trials
Peroral Endoscopic Myotomy Versus Botulinum Toxin Injection in Spastic Esophageal Disorders
Updated: 1/10/2018
Peroral Endoscopic Myotomy Versus Botulinum Toxin Injection in the Treatment of Medical Refractory Spastic Esophageal Disorders
Status: Enrolling
Updated: 1/10/2018
Peroral Endoscopic Myotomy Versus Botulinum Toxin Injection in Spastic Esophageal Disorders
Updated: 1/10/2018
Peroral Endoscopic Myotomy Versus Botulinum Toxin Injection in the Treatment of Medical Refractory Spastic Esophageal Disorders
Status: Enrolling
Updated: 1/10/2018
Click here to add this to my saved trials
Computerized Cognitive Intervention in the Oldest-Old
Updated: 1/10/2018
Computerized Cognitive Intervention in the Oldest-Old: A Feasibility Study
Status: Enrolling
Updated: 1/10/2018
Computerized Cognitive Intervention in the Oldest-Old
Updated: 1/10/2018
Computerized Cognitive Intervention in the Oldest-Old: A Feasibility Study
Status: Enrolling
Updated: 1/10/2018
Click here to add this to my saved trials
Computerized Cognitive Intervention in the Oldest-Old
Updated: 1/10/2018
Computerized Cognitive Intervention in the Oldest-Old: A Feasibility Study
Status: Enrolling
Updated: 1/10/2018
Computerized Cognitive Intervention in the Oldest-Old
Updated: 1/10/2018
Computerized Cognitive Intervention in the Oldest-Old: A Feasibility Study
Status: Enrolling
Updated: 1/10/2018
Click here to add this to my saved trials
Effects of Vaporized Marijuana on Neuropathic Pain
Updated: 1/11/2018
CCRC: The Analgesic Effect of Vaporized Cannabis on Neuropathic Pain
Status: Enrolling
Updated: 1/11/2018
Effects of Vaporized Marijuana on Neuropathic Pain
Updated: 1/11/2018
CCRC: The Analgesic Effect of Vaporized Cannabis on Neuropathic Pain
Status: Enrolling
Updated: 1/11/2018
Click here to add this to my saved trials
Dose Finding and Safety Study of Deferoxamine in Patients With Brain Hemorrhage
Updated: 1/11/2018
Safety and Tolerability of Deferoxamine in Acute Cerebral Hemorrhage
Status: Enrolling
Updated: 1/11/2018
Dose Finding and Safety Study of Deferoxamine in Patients With Brain Hemorrhage
Updated: 1/11/2018
Safety and Tolerability of Deferoxamine in Acute Cerebral Hemorrhage
Status: Enrolling
Updated: 1/11/2018
Click here to add this to my saved trials
A Pediatric Drug Study to Determine the Long-term Safety and Tolerability in Children and Adolescents (4-17 Years in Age) Taking the Drug
Updated: 1/11/2018
An Open-label Eslicarbazepine Acetate Long-term Safety and Tolerability Study in Children and Adolescents (4 - 17 Years)
Status: Enrolling
Updated: 1/11/2018
A Pediatric Drug Study to Determine the Long-term Safety and Tolerability in Children and Adolescents (4-17 Years in Age) Taking the Drug
Updated: 1/11/2018
An Open-label Eslicarbazepine Acetate Long-term Safety and Tolerability Study in Children and Adolescents (4 - 17 Years)
Status: Enrolling
Updated: 1/11/2018
Click here to add this to my saved trials
Delirium in Persons With Dementia
Updated: 1/11/2018
Delirium in Persons With Dementia
Status: Enrolling
Updated: 1/11/2018
Delirium in Persons With Dementia
Updated: 1/11/2018
Delirium in Persons With Dementia
Status: Enrolling
Updated: 1/11/2018
Click here to add this to my saved trials
Use of Neuromuscular Electrostimulation (NMES) for Treatment or Prevention of ICU-Associated Weakness
Updated: 1/12/2018
Use of Neuromuscular Electrostimulation (NMES) for Treatment or Prevention of ICU-Associated Weakness
Status: Enrolling
Updated: 1/12/2018
Use of Neuromuscular Electrostimulation (NMES) for Treatment or Prevention of ICU-Associated Weakness
Updated: 1/12/2018
Use of Neuromuscular Electrostimulation (NMES) for Treatment or Prevention of ICU-Associated Weakness
Status: Enrolling
Updated: 1/12/2018
Click here to add this to my saved trials
Integrated Brain, Body and Social Intervention for Attention Deficit Hyperactivity Disorder (ADHD)
Updated: 1/12/2018
Integrated Brain, Body and Social Intervention (IBBS) for Attention Deficit Hyperactivity Disorder (ADHD)
Status: Enrolling
Updated: 1/12/2018
Integrated Brain, Body and Social Intervention for Attention Deficit Hyperactivity Disorder (ADHD)
Updated: 1/12/2018
Integrated Brain, Body and Social Intervention (IBBS) for Attention Deficit Hyperactivity Disorder (ADHD)
Status: Enrolling
Updated: 1/12/2018
Click here to add this to my saved trials
Integrated Brain, Body and Social Intervention for Attention Deficit Hyperactivity Disorder (ADHD)
Updated: 1/12/2018
Integrated Brain, Body and Social Intervention (IBBS) for Attention Deficit Hyperactivity Disorder (ADHD)
Status: Enrolling
Updated: 1/12/2018
Integrated Brain, Body and Social Intervention for Attention Deficit Hyperactivity Disorder (ADHD)
Updated: 1/12/2018
Integrated Brain, Body and Social Intervention (IBBS) for Attention Deficit Hyperactivity Disorder (ADHD)
Status: Enrolling
Updated: 1/12/2018
Click here to add this to my saved trials
Integrated Brain, Body and Social Intervention for Attention Deficit Hyperactivity Disorder (ADHD)
Updated: 1/12/2018
Integrated Brain, Body and Social Intervention (IBBS) for Attention Deficit Hyperactivity Disorder (ADHD)
Status: Enrolling
Updated: 1/12/2018
Integrated Brain, Body and Social Intervention for Attention Deficit Hyperactivity Disorder (ADHD)
Updated: 1/12/2018
Integrated Brain, Body and Social Intervention (IBBS) for Attention Deficit Hyperactivity Disorder (ADHD)
Status: Enrolling
Updated: 1/12/2018
Click here to add this to my saved trials
Integrated Brain, Body and Social Intervention for Attention Deficit Hyperactivity Disorder (ADHD)
Updated: 1/12/2018
Integrated Brain, Body and Social Intervention (IBBS) for Attention Deficit Hyperactivity Disorder (ADHD)
Status: Enrolling
Updated: 1/12/2018
Integrated Brain, Body and Social Intervention for Attention Deficit Hyperactivity Disorder (ADHD)
Updated: 1/12/2018
Integrated Brain, Body and Social Intervention (IBBS) for Attention Deficit Hyperactivity Disorder (ADHD)
Status: Enrolling
Updated: 1/12/2018
Click here to add this to my saved trials
Safety and Efficacy of Eculizumab in Refractory Generalized Myasthenia Gravis (REGAIN Study)
Updated: 1/12/2018
A Randomized, Double-Blind, Placebo-Controlled, Multi-Center Study to Evaluate the Safety and Efficacy of Eculizumab in Subjects With Refractory Generalized Myasthenia Gravis (gMG)
Status: Enrolling
Updated: 1/12/2018
Safety and Efficacy of Eculizumab in Refractory Generalized Myasthenia Gravis (REGAIN Study)
Updated: 1/12/2018
A Randomized, Double-Blind, Placebo-Controlled, Multi-Center Study to Evaluate the Safety and Efficacy of Eculizumab in Subjects With Refractory Generalized Myasthenia Gravis (gMG)
Status: Enrolling
Updated: 1/12/2018
Click here to add this to my saved trials
Safety and Efficacy of Eculizumab in Refractory Generalized Myasthenia Gravis (REGAIN Study)
Updated: 1/12/2018
A Randomized, Double-Blind, Placebo-Controlled, Multi-Center Study to Evaluate the Safety and Efficacy of Eculizumab in Subjects With Refractory Generalized Myasthenia Gravis (gMG)
Status: Enrolling
Updated: 1/12/2018
Safety and Efficacy of Eculizumab in Refractory Generalized Myasthenia Gravis (REGAIN Study)
Updated: 1/12/2018
A Randomized, Double-Blind, Placebo-Controlled, Multi-Center Study to Evaluate the Safety and Efficacy of Eculizumab in Subjects With Refractory Generalized Myasthenia Gravis (gMG)
Status: Enrolling
Updated: 1/12/2018
Click here to add this to my saved trials
Safety and Efficacy of Eculizumab in Refractory Generalized Myasthenia Gravis (REGAIN Study)
Updated: 1/12/2018
A Randomized, Double-Blind, Placebo-Controlled, Multi-Center Study to Evaluate the Safety and Efficacy of Eculizumab in Subjects With Refractory Generalized Myasthenia Gravis (gMG)
Status: Enrolling
Updated: 1/12/2018
Safety and Efficacy of Eculizumab in Refractory Generalized Myasthenia Gravis (REGAIN Study)
Updated: 1/12/2018
A Randomized, Double-Blind, Placebo-Controlled, Multi-Center Study to Evaluate the Safety and Efficacy of Eculizumab in Subjects With Refractory Generalized Myasthenia Gravis (gMG)
Status: Enrolling
Updated: 1/12/2018
Click here to add this to my saved trials
Safety and Efficacy of Eculizumab in Refractory Generalized Myasthenia Gravis (REGAIN Study)
Updated: 1/12/2018
A Randomized, Double-Blind, Placebo-Controlled, Multi-Center Study to Evaluate the Safety and Efficacy of Eculizumab in Subjects With Refractory Generalized Myasthenia Gravis (gMG)
Status: Enrolling
Updated: 1/12/2018
Safety and Efficacy of Eculizumab in Refractory Generalized Myasthenia Gravis (REGAIN Study)
Updated: 1/12/2018
A Randomized, Double-Blind, Placebo-Controlled, Multi-Center Study to Evaluate the Safety and Efficacy of Eculizumab in Subjects With Refractory Generalized Myasthenia Gravis (gMG)
Status: Enrolling
Updated: 1/12/2018
Click here to add this to my saved trials
Safety and Efficacy of Eculizumab in Refractory Generalized Myasthenia Gravis (REGAIN Study)
Updated: 1/12/2018
A Randomized, Double-Blind, Placebo-Controlled, Multi-Center Study to Evaluate the Safety and Efficacy of Eculizumab in Subjects With Refractory Generalized Myasthenia Gravis (gMG)
Status: Enrolling
Updated: 1/12/2018
Safety and Efficacy of Eculizumab in Refractory Generalized Myasthenia Gravis (REGAIN Study)
Updated: 1/12/2018
A Randomized, Double-Blind, Placebo-Controlled, Multi-Center Study to Evaluate the Safety and Efficacy of Eculizumab in Subjects With Refractory Generalized Myasthenia Gravis (gMG)
Status: Enrolling
Updated: 1/12/2018
Click here to add this to my saved trials
Safety and Efficacy of Eculizumab in Refractory Generalized Myasthenia Gravis (REGAIN Study)
Updated: 1/12/2018
A Randomized, Double-Blind, Placebo-Controlled, Multi-Center Study to Evaluate the Safety and Efficacy of Eculizumab in Subjects With Refractory Generalized Myasthenia Gravis (gMG)
Status: Enrolling
Updated: 1/12/2018
Safety and Efficacy of Eculizumab in Refractory Generalized Myasthenia Gravis (REGAIN Study)
Updated: 1/12/2018
A Randomized, Double-Blind, Placebo-Controlled, Multi-Center Study to Evaluate the Safety and Efficacy of Eculizumab in Subjects With Refractory Generalized Myasthenia Gravis (gMG)
Status: Enrolling
Updated: 1/12/2018
Click here to add this to my saved trials